SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VPHM - Viropharma Inc -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (96)7/14/1999 3:29:00 PM
From: scaram(o)uche  Read Replies (1) | Respond to of 2557
 
Peter:

Ventilated patients, asthmatics....... looks good for meningitis, and the study described in yesterday's release will (IMO) make it into the hands of detail reps. I'd say that prophylaxis of colds in high-risk patients will begin immediately after approval.

One can put estimates all over the block for plec. Nobody [knowledgeable] is going to tell you that it won't do $3 billion/year.

I'm comfortable with $80M.

:-)

Rick


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News